1887
Articles Open Access
Like 0
This item has no PDF Download

    Haemolytic uraemic syndrome, E. coli O157 infection, and antimicrobial therapy – clinical management in the face of scientific uncertainty separator commenting unavailable

  • K Mølbak
  • View Citation Hide Citation

    Citation style for this article: Mølbak K. Haemolytic uraemic syndrome, E. coli O157 infection, and antimicrobial therapy – clinical management in the face of scientific uncertainty. Euro Surveill. 2002;6(37):pii=1887. https://doi.org/10.2807/esw.06.37.01887-en Received: ;   Accepted:

Abstract

The use of antimicrobial agents in the management of patients with E. coli O157 infection is controversial. Verocytotoxigenic Escherichia coli (VTEC), including E. coli O157:H7, is an important cause of gastrointestinal illness. Infection typically presents as a diarrhoeal illness, often with bloody stools. In approximately 8% of patients with E. coli O157:H7, infection progresses to hemolytic-uraemic syndrome (HUS), a life threatening condition characterised by microangiopathic hemolytic anemia, thrombocytopenia, and renal failure. HUS is also associated with VTEC belonging to other E. coli serogroups, although less common than in E. coli O157.

Loading

Article metrics loading...

/content/10.2807/esw.06.37.01887-en
2002-09-11
2017-11-18
http://instance.metastore.ingenta.com/content/10.2807/esw.06.37.01887-en
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurvweeklyarchive/6/37/art01887-en.htm?itemId=/content/10.2807/esw.06.37.01887-en&mimeType=html&fmt=ahah
Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error